IRWD FY 2015 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IRWDIronwood Pharmaceuticals, Inc.

$603M

FY 2015 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$150M+95.7% YoY

Gross Profit

$150M100.0% margin

Operating Income

-$102M-68.3% margin

Net Income

-$143M-95.4% margin

EPS (Diluted)

$-1.00

Cash Flow

Operating Cash Flow

-$107M

Free Cash Flow

-$111M

Stock-Based Comp.

$25M

Balance Sheet

Total Assets

$619M

Total Liabilities

$524M

Stockholders' Equity

$95M

Cash & Equivalents

$261M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$150M	$76M	+95.7%
Gross Profit	$150M	$51M	+194.1%
Operating Income	-$102M	-$169M	+39.7%
Net Income	-$143M	-$190M	+24.8%